Patents/Assignees

HUTCHISON MEDIPHARMA LIMITED

14 patents in portfolio

US12617861utility2026
Anti-ox40 Antibody and Method of Treatment
0 cites
US12559472utility2026
Salts of a Compound and the Crystalline Forms Thereof
0 cites
US12492210utility2025
Tricyclic Compounds and Their Use
0 cites
US12435062utility2025
Amide Compounds and Uses Thereof
0 cites
US12234211utility2025
Cycloolefin Substituted Heteroaromatic Compounds and Their Use
0 cites
US12180214utility2024
Crystalline Forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as Inhibitors of Phosphatidylinositol-3-kinase
0 cites
US12173008utility2024
Substituted Piperazines as BTK Inhibitors
0 cites
US12134613utility2024
Method for the Manufacture of 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and Polymorphic Forms Thereof
0 cites
US12084441utility2024
Salts of a Compound and the Crystalline Forms Thereof
0 cites
US12070457utility2024
Substituted Pyridines, Pyridazines, Pyrimidines, and 1,2,3-triazines as Bruton's Tyrosine Kinase Inhibitors
0 cites
US12030951utility2024
Anti-ox40 Antibody and Uses Thereof
0 cites
US11896592utility2024
Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
0 cites
US11655254utility2023
Substituted Piperazines as BTK Inhibitors
0 cites
US11584750utility2023
Crystalline Forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as Inhibitors of Phosphatidylinositol-3-kinase
0 cites